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Antibodies with high titer and affinity to small molecule are critical in the field for the development of vaccines 
against drugs of abuse, antidotes to toxins and immunoassays for compounds. However, little is known regarding 
how properties of small molecule per se influence and which chemical descriptor could indicate the degree of the 
antibody response. Based on our previous study, we designed and synthesized two groups of small molecules, called 
haptens, with varied hydrophobicities to investigate the relationship between properties of small molecules and 
antibody response in term of titer and affinity. We found that the magnitude of the antibody response is positively 
correlated with the degree of molecular hydrophobicity and related chemical descriptors. This study provides insight 
into the immunological characteristics of small molecules themselves and useful clues to produce high–quality 
antibodies against small molecules. 
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Since the last century, antibodies have been highly 
successful in biomedicine, biochemistry and 
bioanalysis [1]. Antibodies are glycoproteins derived 
from the humoral immune naturally responding to 
macromolecules such as bacteria, viruses and proteins. 
In the case of low–molecular–weight compounds 
(<1000 Da), such as pharmaceuticals, poisons and drugs 
of abuse, these small molecules cannot be effectively 
recognized by the immune system to induce a 
subsequent antibody response [2]. To produce 
antibodies against small molecules, structural analogs 
of targets, named haptens, should be conjugated to 
larger molecules, called carriers. As well–established 
biological reagents, thousands of antibodies against 
hapten molecules with varied titers and affinities have 
been produced [3]. Unlike antibodies to 
macromolecules, desired antibodies to haptens should 
possess not only high titer but also high affinity for the 
free molecule, which is essential for their use as 
biopharmaceutics, antidotes and immunoprobes. Some 
factors, including hapten design, coupling chemistry, 
hapten-carrier ratio, carrier type and adjuvant 
formulation, have been reported to influence antibody 
response and then antibody formation, as they affect 
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presentation of the hapten molecule and thus the quality 
of the immune response [4]. Nowadays, little is known 
regarding what primarily guarantees a high–quality 
antibody response to a hapten. In the author’s opinion 
and experience, the decisive factor for antibody 
response should be the hapten itself; however, how 
hapten properties themselves influence and which 
molecular descriptors can indicate or even predict the 
degree of the antibody response is poorly understood. 
To address this question, it is critical to deepen our 
understanding of the immunogenicity of small 
molecules, of course, after conjugating to carriers, 
which will be useful to produce the desired antibody 
with excellent titer and affinity. Systematic 
investigation of the relationship between properties of 
small molecules and antibody response is 
experimentally challenging due to the large number of 
variables and the limited number of typical molecular 
models. Recently, we successfully produced the 
antibodies against trimethoprim by preferentially 
exposing the hydrophilic dimethamine of trimethoprim, 
resulting in a surprisingly high titer and affinity (Figure 
1 and Table S1) [5]. Compared with the antibodies 
obtained by exposing the hydrophobic 
trimethoxyphenyl of trimethoprim in the other reports, 
the affinity (expressed as IC50 values) of our antibodies 
are improved by 10–90–fold with higher titers [6]. 
*Manuscript
These results reveal that the hydrophilic groups of 
haptens seem to account more for a strong antibody 
response than the hydrophobic groups of haptens. 
However, recent studies on the immunogenicity and 
haptenic character of poly (ethylene glycol) (PEG) and 
other nanoparticles showed that hydrophilic materials 
usually bear a lower immunogenicity than their 
hydrophobic counterparts [7]. These opposite results 
motived us to examine whether the capacity of small 
molecule to induce antibody response is related with its 
hydrophobic degree. If not, which of its molecular 
descriptors could suitably indicates the immunogenicity 
of small molecule? Since the small molecule itself has 
the most critical impact on antibody response in the 
author’s opinion.  
 
Figure 1. Chemical structures of haptens. Hapten1a mimics the 
trimethoxyphenyl of trimethoprim and is synthesized by us. 
Hapten1b mimics the diaminopyrimidine of trimethoprim and is 
a commercial compound. Hapten2 group were intentionally 
designed and synthesized with significantly different 
hydrophobicities. The molecular descriptors of haptens which 
excluding the spacer arm were calculated. Dipole moment, μ; 
molecular polarity index, MPI. 
To understand the immunogenic attributes of small 
molecules, a simple and logical experiment based on 
simplified models is necessary. According to the 
immunizing results of trimethoxyphenyl, we firstly 
divided trimethoprim into two parts and separately 
verified the capacity of two resultant haptens to induce 
an antibody response. As shown in Figure 1, the 
proposed Hapten1a (in red) mimics the hydrophilic 
dimethamine moiety of TMP and Hapten1b (in blue) 
resembles the hydrophobic trimethoxyphenyl moiety of 
TMB. Secondly, we intentionally designed Hapten2 
group with simple structure, which comprised three 
novel compounds with similar molecular weights and 
obviously different hydrophobicities (Figure 1). Based 
on the structural characteristics of three compounds, the 
order of hydrophobicity is expected to be: Hapten2c > 
Hapten2b > Hapten2a.The key point in the design of 
these haptens was the use of the same spacer arm, thus 
providing structural uniformity to remove the usual 
“bridge effects” arising from the linker between the 
hapten and carrier protein [8]. In addition, the similar 
molecular weight of members of the Hapten2 group 
ensured a fair comparison, since molecular weight is 
thought to be an important factor in immunogenicity of 
small molecule [9]. 
To ensure the rationality and practicability of these 
haptens designed, we firstly evaluate their 
hydrophobicity by using calculation chemistry with the 
M06–2X density functional and TZVP basis set before 
synthesis [10]. After obtaining the minimum 
conformations of the haptens excluding the spacer arm 
(Figure S4), the maps of electrostatic potential (ESP) 
mapped van der Waals surface of all haptens are 
constructed since ESP are closely related to the 
hydrophobicity of small molecules and could be as an 
indicator [11]. In addition, we calculated area 
distribution of different ESP intervals on the van der 
Waals surface. As shown in Figure 2A, the neutral 
regions in white of Hapten1a account for a large 
proportion of van der Waals surface due to the 
trimethoxyphenyl. In Hapten2，the hapten2c present 
predominantly neutral with some negative regions at the 
position of phenyl, is different from hapten2a and 
hapten2b which have obviously positive ESP in red at 
amino group and carboxyl group respectively (Figure 
2B). More detail, the ESP surface area of Hapten1a is 
equably distributed between -30 kcal/mol and 30 
kcal/mol while that of Hapten1b is concentrated in a 
narrower range of 0-20 kcal/mol which illustrates a 
more even surface distribution, roughly implying that 
Hapten1a possessing significantly lower 
hydrophobicity than Hapten1b. Similarly, in the group 
of Hapten2, by comparing the uniformity of ESP 
distribution, Hapten2c provides the highest molecular 
hydrophobicity followed by Hapten2b and then 
Hapten2a (Figure 2B). The calculated hydrophobicity 
 
 
Figure 2. Electrostatic potential (ESP) mapped van der Waals surface (i.e. ρ = 0.001 a.u. isosurface) and area distribution of ESP 
intervals of (A) Hapten1 and (B) Hapten 2. The negative ESP regions are indicated in blue, the positive regions in red and the neutral 
regions in white. 
 
of haptens support the practicability of these haptens we 
designed to study the influence of molecular 
hydrophobicity on antibody response. After 
confirmation by computational chemistry, the hapten1a 
and three haptens in Hapten2 group were totally 
synthesized in four or five steps (Scheme 1, 2, 3) since 
the hapten1b is commercially available. The detailed 
synthesis and characterization of haptens were provided 
in Supporting information (Figure S1). 
To conjugate the haptens on a carrier protein, 
carboxylic acids of all hapten molecules were activated 
with N–hydroxysulfosuccinimide and 
dicyclohexylcarbodiimide and then treated with bovine 
serum albumin (BSA) as immunogens and ovalbumin 
(OVA) as coating antigens. Since the hapten–carrier 
ratio could influence the antibody response in animals 
and the subsequent antibody test [4b, 12], it was 
controlled carefully in the reasonable range of 13.4 to 
17.0 for hapten–BSA and 4.4 to 5.3 for hapten–OVA, 
respectively (Figure S2–S3 and Table S2). Each 
hapten–BSA conjugate was used to immunize a set of 
10 BALB/c mice with a total of three times at 25–day 
intervals. The use of 10 mice per hapten minimized the 
risk of obtaining results overly biased by any individual 
mouse (Table S4). Antisera are composed of the entire 
distribution of IgG antibodies present in mouse and 
provide a comprehensive view of general trends 
associated with the overall antibody response. 
Thus, antisera titer and affinity were assessed by 
both noncompetitive ELISA and competitive ELISA 
against the corresponding homologous coating antigen, 
respectively (described in Supporting information). In 
the experiment, antibody titer is defined as the dilution 
of antisera that furnished an ODmax between 1.5 and 2.0, 
while antibody affinity is expressed as the inhibition 
ratio calculated according to an equation (Supporting 
information). 
Scheme 1. Synthesis of Hapten1a 
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Scheme 2. Synthesis of Hapten2b and Hapten2a 
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Scheme 3. Synthesis of Hapten2c 
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In short, a higher antibody dilution or inhibition 
ratio indicates a higher antibody response. As shown in 
Figure 3A, both Hapten1a and Hapten1b induced a 
significant antibody response. A general trend of 
gradually increasing titer as immunization continued 
was seen. Importantly, the antibody titers from 
Hapten1b were obviously higher than those from 
Hapten1a. During the immunization period, the 
antibody titers of Hapten1b were always 10–fold higher 
than those of Hapten1a, implying a stronger immune 
response achieved by more hydrophobic Hapten1b 
(Figure 3A). The performance of antibodies against 
small molecules should be judged by not only titer but 
also affinity. The latter is practically more important in 
the fields of bioanalysis, biochemistry and biomedicine 
in most cases. Unexpectedly, the antibodies induced by 
Hapten1a showed a rather poor affinity with an 
inhibition ratio of only 1%, unlike the antibodies 
induced by Hapten1b, which showed a greater than 75% 
inhibition ratio after the third immunization (Figure 3B). 
Furthermore, no improvement in the inhibition ratio of 
antisera for Hapten1a was observed, while the 
inhibition ratio of Hapten1b slowly increased with 
subsequent immunizations. These results reveal an 
obvious relationship between hydrophobicity of small 
molecule and antibody response, i.e., a higher degree of 
hydrophobicity of small molecule induced a stronger 
antibody response, which is opposite to our initial 
hypothesis supported by our previous study of 
trimethoprim [5].  
To examine the unexpected relationship, three 
well–designed Hapten2 with varied hydrophobicity are 
then evaluated as shown in Figure 3C and 3D. The titers 
and affinities of all Hapten2 analogs increased sharply 
as immunizations continued, and an improvement in 
titer of at least 3–fold was achieved at the end of 
immunization. Similarly, a clear and definite 
relationship between hydrophobicity of small molecule 
and antibody titer was again observed with no exception. 
Moreover, both the highest antibody titer and the 
highest affinity of the antisera were obtained from the 
most hydrophobic hapten, Hapten2c. The titer and 
inhibition ratio of Hapten2c after the third 
immunization was approximately 7– and 10–fold, 2– 
and 3–fold higher those of Hapten2b and Hapten2a, 
respectively, demonstrating that the degree of small 
molecule hydrophobicity was positively correlated with 
the magnitude of the antibody response, at least in the 
case of the haptens we prepared. There is little 
difference in affinity between Hapten2a and Hapten2b, 
which may be related to similar ESP distribution on 
molecular surface of the two haptens (Figure 2B). These 
findings demonstrate the similarity between small 
molecules and polymers, nanomaterials and proteins, 
whose hydrophobicity significantly influences their 
antibody response [7]. Notably, the titers and affinities 
of all five evaluated haptens in this study were not high, 
and the IC50 values for the haptens determined by 
ELISA were all at the μg/mL level (data not shown), 
which can be ascribed to the very low molecular weight 
and simple structures of these haptens.  
To identify the appropriate molecular descriptors 
to indicate the ability of small molecule inducing 
antibody response, we extracted physicochemical 
descriptors of haptens such as LogP, molecular 
 
Figure 3. Evaluation of antibody titer and affinity. Antibody titers tested by homologous ELISA using serum from mice (n=10/group) at the 
1st, 2nd and 3rd immunization. The titer is defined to be the dilution of antisera when furnishing ODmax between 1.5 and 2.0. Inhibition 
ratios representing antibody affinities measured by homologous ELISA for their corresponding hapten using serum from mice (n=10/group) 
at the 1st, 2nd and 3rd immunization. The inhibition ratio is calculated according to an equation described in supporting information. The 
higher inhibition ratio represents the higher antibody affinity. ＊P <0.05 determined by one–way ANOVA. (A) Antibody titer of Hapten1 
(B) Inhibition ratio of Hapten1 (C) Antibody titer of Hapten2 (D) Inhibition ratio of Hapten2. 
 
volume/surface, etc. (described in Supporting information 
and shown in Table S3) [10]. As shown in Table S3 and 
S5, only descriptors related to hydrophobicity, such as 
dipole moment, LogP, polar surface area and molecular 
polarity index (MPI), were observed to be directly 
proportional to the antibody response. MPI is defined for 
quantitatively measuring polarity of molecules based on 
ESP on their van der Waals surface, representing the 
uniformity of ESP distribution. Comparing to dipole 
moment, LogP, polar surface area, in the author’s opinion, 
MPI maybe a better indicator of a hapten ability to induce 
an antibody response since it can be obtained easily and 
appropriately represents the molecular hydrophobicity in 
most cases [13]. 
On the contrary, for example, the dipole moment 
cannot reflect the molecular hydrophobicities of 
symmetrical molecules, such as triacetone triperoxide and 
chlorhexidine. The correlation between MPI and antibody 
affinity was calculated by Person Correlation Matrix and 
the coefficient is -0.838 which is significant at the 0.05 
level (2-tailed). The results clearly demonstrate that the 
MPI is a meaningful molecular descriptor to indicate the 
ability of small molecule inducing antibody response, at 
least in our study.  
Despite this, a positive relationship between hapten 
hydrophobicity and antibody titer was not found between 
groups, for example, Hapten1a vs Hapten2a (Table S5). 
In addition, there have been many reports of exceptional 
small molecules with high hydrophobicity that produce a 
low antibody response, which here mainly refers to 
antibody affinity, such as squalene in comparison to its 
hydrophilic counterpart, etioporphyrin [14]. Furthermore, 
some small molecules with extremely high 
hydrophobicity did not induce an antibody response, such 
as diisononylcyclohexane–1,2–dicarboxylate and di–2–
ethylhexyl terephthalate [15]. These results imply that an 
increase in hydro phobicity of small molecule does not 
always guarantee and improve antibody response, which 
is also influenced by other molecular properties of small 
molecules, such as size, shape, and flexibility, 
complicating the structure–magnitude correlation. 
Further study should be conducted by using more typical 
molecule models with strict control to obtain more precise 
relationship between molecular properties and antibody 
response. 
In summary, we designed two groups of haptens with 
different hydrophobicities and systematically investigated 
the relationship between properties of small molecules 
and antibody response. A highly positive correlation 
between molecular hydrophobicity and antibody response 
was observed. The MPI was suggested to be used as an 
indicator of ability of small molecule inducing antibody 
response. These findings provide a deeper understanding 
of the antibody response of small molecule per se and 
have far–reaching implications for rational hapten design, 
a critical step toward the development of a new generation 
of vaccines against drugs of abuse, antidotes to chemical 
toxins and diagnostic antibodies for small molecules. 
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Table S1. Previous reported haptens of trimethoprim and related conjugation chemistry, IC50 values and titers of antibodies. 
Hapten structures 
Conjugation chemistry Antibody types 
IC50 
(ng/mL) 
Titers 
a
 
References 
The following haptens reported in literatures which all expose diaminopyrimidine to immune system 
 
Glutaraldehyde used as conjugation reagents 
Polyclonal antibody 
from rabbit 
>6.0
b
 1,500 1 
>6.0
b
 -
c
 2 
Monoclonal 
antibody from 
mouse 
 4.14 32,000 3 
 1.98 - 4 
The following three haptens we prepared which much expose diaminopyrimidine moiety to immune system 
 
Dicyclohexylcarbodiimide and 
N-hydroxysuccinimide used as conjugation 
reagents 
Monoclonal 
antibody from 
mouse  
  
0.232 16,000 5 
0.067 60,000 
6 
0.2 20,000 
 
Dicyclohexylcarbodiimide and 
N-hydroxysuccinimide used as conjugation 
reagents 
0.15 40,000 
0.24 40,000 
 
Dicyclohexylcarbodiimide and 
N-hydroxysuccinimide used as conjugation 
reagents 
0.17 60,000 
a The titer here was defined that the concentration of antibody generated the OD values ranged 1.5 to 2.0.  
b The papers have not reported IC50 values and only provided detection limits. Usually the IC50 value was about 10 times of detection limit in an immunoassay. 
 
c Not exhibited in the work. 
S5 
 
1. Materials and apparatus 
Bovine serum albumin (BSA), horseradish peroxidase (HRP), N-hydroxysuccinimide (NHS), 
and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). The substrate 3,3,5,5-tetramethylbenzidine (TMB) system was obtained 
from the Beijing WDWK Biotechnology Co., Ltd. (Beijing, China). All other chemicals and 
solvents were of analytical grade or better and were obtained from the Beijing Chemical Reagent 
Co. (Beijing, China). Reverse osmosis water, pyrogen free (RO water) was prepared using a 
Milli-Q water purification system (Millipore, Bedford, MA, USA).  
2. Buffers 
The common buffer solutions used in the experiment are listed: (1) coating buffer (0.05 
mol/L) carbonate buffer, pH 9.6); (2) phosphate buffer solution (PBS buffer, 0.01 mol/L, pH 7.4); 
(2) blocking buffer (2% skim milk powder (w/v)); (3) washing buffer (PBST, 10 mmol L
−1
 PBS 
buffer with 0.05% Tween-20 (v/v)), pH 7.2); (4) antibody diluent buffer (10 mmol/L washing 
buffer with 0.2% albumin, (w/v)); (5) Goat anti-mouse IgG (HRP labeled) dilution buffer (PBS 
buffer containing 5% albumin (w/v)); (7) stopping reagent (2 mol/L H2SO4). 
3. Apparatus 
Polystyrene microplates were obtained from Corning Inc (Costar 2592, Corning, NY, USA). 
Optical density (OD) was recorded on SpectraMax M5 (Downingtown, PA, USA). The chemical 
structures of all haptens were confirmed by liquid chromatography triple quadrupole mass 
spectrometry (Thermo, USA) and nuclear magnetic resonance spectrometry (NMR) DRX (Bruker, 
Rheinstetten, Germany). The conjugation ratio was determined by matrix-assisted laser desorption 
ionization time of flight mass spectrometry (MALDI–TOF-MS) (Bruker, Rheinstetten, Germany).  
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4. Synthesis and characterization of haptens 
4.1 Synthesis of Hapten1a  
 
Scheme 1. The synthetic route of Hapten1a. 
Hapten1a was prepared based on the following scheme in 5 steps. 
Step 1  Synthesis of compound 3 （2,4-diaminopyrimidine-5-carbonitrile） 
 
Guanidine hydrochloride (19.11 g, 200 mmol) was suspended in anhydrous ethanol (600 mL), 
2-(ethoxymethylene)malononitrile (27.20 g, 200 mmol) was added in one portion. The mixture 
was stirred at ambient for 10 min. Sodium ethoxide (6.80 g, 100 mmol) was added in 2 portions in 
10 min. The reaction mixture was heated at 81 °C (oil bath) for 2 h and then incubated at ambient 
temperature (25 
o
C) for 16 h. Solvent was removed in vacuum to give a yellow residue. Sat. 
ammonium chloride (500 mL) and pure water (100 mL) were added to the residue. The resulting 
mixture was stirred for 10 min, filtered, and then the desired product (24.01 g, 177.85 mmol, 89%). 
1
H NMR (300 MHz, DMSO-d6) δ 6.93 (s, br, 2H) 7.10 (s, br, 2H), 8.17 (s, 1H) was obtained by 
drying the yellow solid in vacuum. 
Step 2  Synthesis of compound 4 （2,4-diaminopyrimidine-5-carbaldehyde） 
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Compound 3 (24.01 g, 177.80 mmol) was added to a slurry of Raney nickel (50% in water, 
20.00 g) followed by addition of formic acid (88% in water, 200 mL). The resulting mixture was 
then heated under reflux (125 
o
C, oil bath) for 7 h. Then stirred at ambient temperature for 16 h. 
The reaction mixture was filtered, the cake was washed with formic acid (100 mL). The filtrate 
was combined and concentrated to afford a yellow residue. The residue was poured onto ammonia 
(28%, 200 mL). The resulting mixture was stirred for 30 min. The yellow solid was collected by 
filtration, dried in hot air to gain a yellow solid (21.09 g, 86%) as desired product (
1
H NMR (300 
MHz, DMSO- d6) δ 7.13 (s, 2H) 7.54 (s, br, 1H), 7.82 (s, br, 1H), 8.32 (s, 1H), 9.46 (s, 1H)).  
Step 3  Synthesis of compound 6 （(E)-ethyl 3-(2,4-diaminopyrimidin-5-yl)acrylate） 
 
A suspension of compound 4 (5.52 g, 40 mmol), compound 5 (16.70 g, 48 mmol) in DMF 
(100 mL) was heated at 120 
o
C for 4 h. The mixture was cooled to room temperature. Water (400 
mL) was added to the residue then stirred for 30 min. Yellow precipitate appeared. The mixture 
was extracted with ethyl acetate (400 mL × 4). The combined organic layers were washed with 
water (600 mL), brine (600 mL), dried Na2SO4. Solvent removal under vacuum gave a yellow 
powder (19.02 g). The powder was washed with a mixture of petroleum ether and ethyl acetate 
(1:1, 200 mL × 3) and concentrated to give a powder as desired product (3.20 g, 38%). 
Step 4  Synthesis of compound 7 （ethyl 3-(2,4-diaminopyrimidin-5-yl)propanoate） 
 
A mixture of compound 6 (3.20 g, 15.30 mmol), palladium on carbon (10%, 1.00 g) in 
ethanol (150 mL) was hydrogenated at 50 
o
C under a hydrogen balloon for 48 h. The mixture was 
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cooled to room temperature. Palladium on carbon was removed by filtration. The filtrate was 
concentrated to afford a residue (3.10 g). The mixture was refluxed in a mixture of MeOH and 
CHCl3 (1:3, 100 mL) and filtered. The solid was discarded. The filtrate was concentrated to give a 
residue, which was washed with a mixture of petroleum ether and dichloromethane (10:1, 40 mL × 
2) to give a residue as desired crude product (2.10 g, 62%). The material was used in next step 
without further purification. 
Step 5 Synthesis of Hapten1a 
 
To a suspension of compound 7 (2.10 g, crude, 10 mmol) in MeOH (15 mL) was added a 
solution of NaOH (2.40 g, 60 mmol) in water (15 mL). The resulting mixture was stirred at room 
temperature for 2 h. TLC monitoring indicated that compound 7 was consumed completely. The 
mixture was neutralized with HCl (3 M, 20 mL) to adjust pH value to 3-4. The mixture was 
extracted with dichloromethane (20 mL × 3). The aqueous layer was concentrated to give a residue. 
The residue was refluxed in a mixture of MeOH and water (5:1, 60 mL) and filtered while hot. 
The filtrate was concentrated to give a residue. The residue was refluxed in a mixture of MeOH 
and water (10:1, 55 mL) and filtered while hot. The filtrate was concentrated to give an off-white 
solid as pure target compound (1.50 g, 82%) (1H NMR (300 MHz, D2O) δ 2.65-2.67 (m, 4H), 
7.50 (s, 1H). ESI-MS found 181 (M-H)). 
4.2 Synthesis of Hapten2a and Haten2b 
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Scheme 2. The synthetic route of Hapten2a and Hapten2b. 
Target Hapten2a and Hapten 2b was prepared based on the following scheme. 
Step 1 Synthesis of compound 2 (methyl 2-bromoisonicotinate) 
 
Concentrated sulphate acid (2 mL) dropwise was added to a mixture of compound 1 (20.20 g, 
100 mmol) in MeOH (200 mL). The mixture was heated under reflux for 5 h. The mixture was 
cooled to room temperature. Ethyl acetate (300 mL) was then added. The mixture was washed 
with sat. NaHCO3 to neutral. The mixture was then dried over sodium sulphate. The solvent was 
removed under vacuum to give a light-yellow oil as desired compound 2 (17.20 g, 80%). 
Step 2 Synthesis of compound 4 ((E)-methyl 2-(3-tert-butoxy-3-oxoprop-1-enyl)isonicotinate) 
 
Under nitrogen atmosphere, to a mixture of compound 2 (2.16 g, 10 mmol), potassium 
carbonate (1.65 g, 12 mmol), triethylenediamine (112.30 mg, 1 mmol), Bu4NBr (3.87 g, 12 mmol) 
was added DMF (20 mL) via syringe. Then Pd(OAc)2 (112.3 mg, 0.50 mmol) and compound 3 
(3.20 g, 25 mmol) were added. The mixture was heated at 120 
o
C under nitrogen atmosphere for 6 
h. The mixture was cooled to room temperature. Water (100 mL) was then added. The mixture was 
extracted with dichloromethane (50 mL × 3). The combined organic layers were dried over 
Na2SO4. The mixture was then concentrated. The residue obtained was subject to silica gel column 
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separation (petroleum ether : ethyl acetate=30 :1) to give a light-yellow solid (880 mg, 32 %) as 
desired compound 4. 
Step 3 Synthesis of compound 5 (methyl 2-(3-tert-butoxy-3-oxopropyl)isonicotinate) 
 
To a solution of compound 4 (5.00 g, 19 mmol) in ethyl acetate (60 mL) was added 
palladium on carbon (10%, 2.00 g). The mixture was hydrogenated under hydrogen gas balloon 
for 16 h. The mixture was then filtered to remove the palladium on carbon. The filtrate was 
concentrated to give a light-yellow oil as desired compound 5 (4.73 g, 94%). 
Step 4 Synthesis of Hapten2b 
 
TFA (10 mL) was added to a solution of compound 5 (4.73 g, 17.80 mmol) in 
dichloromethane (30 mL). The mixture was then refluxed for 4 hours. The mixture was cooled to 
room temperature. Solvent was removed under vacuum. To the mixture was added water (50 mL) 
and the pH value was adjusted to 4 with the addition of 1 N HCl. The precipitate was filtered and 
collected and dried under vacuum to give desired Hapten2b as a white solid (2.53 g, 68%). 
1
H 
NMR (400 M Hz, DMSO-d6) δ2.70 (t, J = 7.2 Hz, 2H), 3.07 (t, J = 7.2 Hz, 2H), 3.90 (s, 3H), 
7.65-7.74 (m, 2H), 8.69 (d, J = 4.8 Hz, 1H), 12.13 (s, 1H). 
Step 5 Synthesis of Hapten2a  
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To a mixture of Hapten2b (3.78 g, 18 mmol) in MeOH (40 mL) cooled to 0 
o
C was added a 
solution of methyl amine (4.41 g, 30%, 90 mmol). The mixture was then heated at 50 
o
C for 8 h. 
The mixture was cooled to room temperature and concentrated. Water (50 mL) was added. The pH 
value of the mixture was adjusted to 4 with the addition of 1 N HCl. The precipitate was collected 
via filtration to give a solid. Further drying under vacuum gave a white solid as desired product 3 
(1.72 g, 46%). 
1
H NMR (500 MHz, DMSO-d6) δ 2.71 (t, J = 7.0 Hz, 2H), 2.80 (d, J = 4.5 Hz, 3H), 
3.04 (t, J = 7.0 Hz, 2H), 7.56 (dd, J = 1.5 Hz, 5.5 Hz, 1H), 7.64 (s, 1H), 8.60 (d, J = 5.0 Hz, 1H), 
8.69 (d, J = 4.5 Hz, br, 1H), 12.08 (s, br, 1H). 
4.3 Synthesis of Hapten2c  
 
Scheme 3. The synthetic route of Hapten2c 
Target Hapten3c was prepared based on the following scheme in 4 steps 
Step 1 Synthesis of compound 2 ((E)-3-(prop-1-enyl)benzaldehyde) 
 
A mixture of compound 1 (2.68 g, 20 mmol), ethyltriphenylphosphonium bromide (8.20 g, 22 
mmol), potassium carbonate (4.20 g, 30 mmol) in dioxane (30 mL) and water (1 mL) was heated 
under reflux for 8 h. The reaction mixture was cooled to room temperature. Solvent was removed 
under vacuum. To the residue was added water (50 mL) and extracted with ethyl acetate c (50 mL 
× 3). The combined organic layers were dried over sodium sulphate. Solvent removal gave a 
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residue. The residue was subject to silica gel column chromatography (petroleum ether: ethyl 
acetate = 50 :1) to give a yellow oil (1.54 g, 53 %) as desired compound 2. 
Step 2 Synthesis of compound 4 ((E)-ethyl 3-(3-((E)-prop-1-enyl)phenyl)acrylate) 
 
A mixture of compound 2 (730 mg, 5 mmol) and compound 3 (1.93 g, 5.75 mmol) in toluene 
was refluxed for 3 h. The mixture was cooled down and concentrated. The residue was purified 
with silica gel column (petroleum ether: ethyl acetate = 10 :1) to give a colorless oil as desired 
compound 4 (1.17 g, 100%). 
Step 3 Synthesis of compound 5 (ethyl 3-(3-propylphenyl)propanoate) 
 
To a solution of compound 4 (1.10 g, 5.44 mmol) in ethyl acetate (15 mL) was added 
palladium on carbon (10%, 200 mg). The reaction mixture was hydrogenated under hydrogen gas 
balloon for 16 h at room temperature (25 
o
C). The mixture was filtered to remove the palladium on 
carbon. The filtrate was concentrated to give desired products compound 5 as a yellow oil (1.02 g, 
83%). 
Step 4 Synthesis of Hapten2c 
 
To a suspension of compound 5 (3.00 g, 13.60 mmol) in MeOH (30 mL) was added water (5 
mL) and NaOH (1.97 g, 49 mmol). The mixture was then heated at 80 
o
C for 2 h. The mixture was 
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then cooled to room temperature. MeOH was removed under vacuum. To the reaction mixture was 
added water (20 mL). The pH value of the mixture was adjusted to 2 via addition of 1 N HCl. The 
mixture was extracted with ethyl acetate (50 mL × 3). The combined organic layers were dried 
over sodium sulphate. Solvent removal under vacuum gave a light yellow oil as desired target 
(2.48 g, 94%).
1
H NMR (400 MHz, CDCl3) δ 0.93 (t, J = 5.7 Hz, 3H), 1.58-1.67 (m, 2H), 2.55 (t, J 
= 5.7 Hz, 2H), 2.67 (t, J = 5.7 Hz, 2H), 2.93 (t, J = 6.0 Hz, 2H), 7.01-7.03 (m, 3H), 7.19-7.21 (m, 
1H), 11.32 (s, br, 1H). 
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Figure S1. The mass spectra and
 1
H NMR spectra of (A) Hapten1a, (B) Hapten2a, (C) 
Hapten2b, (D) Hapten2c. 
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5. Preparation and characterization of conjugates  
The haptens with carboxylic acid groups were activated through the active-ester method and 
then coupled to a protein (BSA or OVA). To control the hapten-protein ratios, different 
combination of haptens and protein were optimized (Table S1). For Hapten1a, 12.5 μmol, 14.6 
μmol, 16.7 μmol, 18.7 μmol and 20.8 μmol of hapten1a was dissolved in 1.5 mL DMF, 
respectively, and NHS and DCC were added and mixed in 1.5 molar ratios. The mixture was 
reacted using a magnetic stirrer at room temperature for 6 h followed by the removal of the 
precipitates. The supernatant of mixture was dropwise added into dissolved BSA or OVA in 10 
mL PBS in 1:75, 1:87.5, 1:100, 1:112.5, 1:125 ratio, respectively. In the case of other four haptens, 
5.0 μmol, 5.8 μmol, 6.6 μmol, 7.5 μmol and 8.3 μmol of haptens were used and the molar ratio of 
DCC and NHS was 1:1.5. The molar ratios for hapten/protein were 1:30, :35, 1:40, 1:45, 1:50 
respectively. All hapten-protein conjugates were stirred for 12 h and then dialyzed in PBS for 2 
days. Hapten-BSA served as an immunogen and hapten-OVA acted as coating antigens were 
stored at −20 °C for further use. The conjugation ratios were characterized using 
MALDI–TOF-MS and were calculated as follows: 
Conjugation ratio = {M (conjugates)－M (BSA)}/M (haptens)   (Eq.1). 
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Figure S2. MALDI–TOF-MS of (A) BSA, (B) Hapten1a-BSA, (C) Hapten1b-BSA, (D) Hapten2a 
-BSA, (E)Hapten2b-BSA, (F) Hapten2c-BSA. 
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Figure S3. MALDI–TOF-MS of (A) OVA, (B) Hapten1a-OVA (C) Hapten1b -OVA (D) 
Hapten2a-OVA, (E) Hapten2b-OVA, (F) Hapten2c-OVA.  
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Table S2. The selected conjugates with similar hapten-to-protein molar ratios. 
Immunogens ratios Coating antigens ratios 
Hapten1a-BSA 14.6 Hapten2a-OVA 5.2 
Hapten1b-BSA 14.6 Hapten2b-OVA 4.4 
Hapten2a-BSA 14.4 Hapten2a-OVA 5.3 
Hapten2b-BSA 13.4 Hapten2b-OVA 5.3 
Hapten2c-BSA 17.0 Hapten2c-OVA 5.2 
 
6. The descriptors of haptens obtained by computational chemistry 
All haptens properties excluding spacer arm and trimethoprim (TMP) were built in Gaussian 
09 (Gaussian, Wallingford, CT, USA). Then, the density functional theory (DFT) calculations with 
the M06-2X density functional and TZVP basis set were performed to optimize the haptens 
7-8
. 
The fundamental vibrations were calculated by the same method to confirm whether they were 
true minima or not. The minimum energy conformations of haptens were shown in Figure S4. The 
descriptors of haptens and TMP including dipole moment (μ), the energy of the highest occupied 
molecular orbital (EHOMO) and of the lowest unoccupied molecular orbital (ELUMO), molecular 
energy (E) were directly extracted from output file. Energy difference between the ELUMO and 
EHOMO (ΔELH) were calculated by using Excel. Hydrophobic constant (LogP), cLogP and 
molecular weight (MW)were extracted by using ChemBio3D (PerkinElmer). Molecules volume 
(Vm), surface area (SA), polar surface area (PSA) and molecular polarity index (MPI) were 
extracted by using Multiwfn
9
. Solvent accessible surface areas (SASA) were extracted by using 
VMD 
10
.     
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Figure S4. The minimum energy conformations of haptens which excluding the spacer arm. The 
elements are represented in the following manner: oxygen, red; nitrogen, blue; hydrogen, white; 
and carbon, off white. 
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Table S3. Molecular descriptors of main structure of all haptens  
Haptens 
a
 Hapten1a Hapten1b Hapten2a Hapten2b Hapten2c TMP 
descriptors 
    
 
 
μ 2.2508 1.803 3.818 2.5515 0.4963 4.0933 
PI 15.22 11.08 13.66 11.02 6.90 12.82 
cLogP -0.336 1.4421 0.108 0.767 3.699 0.9811 
LogP -0.28 1.65 -0.16 0.52 3.36 1.43 
MW 110.12 168.19 136.15 137.14 120.2 290.32 
EHOMO -0.26825 -0.25055 -0.32723 -0.33154 -0.29427 -0.26393 
ELUMO 0.024254 0.039589 -0.0302 -0.03798 0.024412 0.017181 
ELH 0.292507 0.290136 0.297032 0.293568 0.31868 0.281107 
E -375.043 -575.756 -456.257 -476.128 -350.136 -988.928 
Vm 136.7412 214.8453 172.7826 167.8135 184.8898 353.1313 
SA 145.2302 211.5105 176.7082 173.2873 185.6047 321.5312 
PSA 95.21 107.46 94.94 89.86 41.14 190.87 
SASA 273.0459 369.1366 313.8543 309.5389 319.3560 497.0549 
a
 Here, the structures used for calculation chemistry is the subtractive haptens which excluding the spacer arm.         
S29 
 
7. Immunization procedure of mice 
Ten female BALB/c mice for each hapten conjugates, 6–8 weeks old, were immunized 
subcutaneously with each 100 µg of immunogens in 0.25 mL of 0.9% NaCl and 0.25 mL of 
Freund incomplete adjuvant. On the 25
th
 and 50
th
 days after the initial injection, mice were 
boosted with 100 µg of immunogen in Freund complete adjuvant. One week after injection, 
antisera samples obtained from the eye socket of mice were collected to detect the sensitivity and 
specificity based on the ELISA. 
Table S4. The information of immunization procedures 
Immunogens Dose/mouse Number of immunizations Interval time (d) Number of mice 
Hapten1a-BSA 100 g 3 25 10 
Hapten1b-BSA  100 g 3 25 10 
Hapten2a-BSA 100 g 3 25 10 
Hapten2b-BSA 100 g 3 25 10 
Hapten2c-BSA 100 g 3 25 10 
 
8. The determination of titers and affinity 
8.1 The determination of titers  
The titers of antibody were determinated by noncompetitive ELISA and the dilution of 
antibody when furnishing ODmax between 1.5 and 2.0 as the following procedure: polystyrene 
96-well microtiter plates were coated with each homogenous coating antigen (100 µL/well) 
incubated at 4 C overnight. The plates were washed three times with washing buffer, and then 
blocked with blocking buffer (300 L/well) at 37 C for 1 h. Antibody (100 µL/well) were added 
to wells. Unbound compounds were removed by washing solution after incubation for 30 min at 
37 C. Goat anti-mouse IgG-HRP (1/5000 in PBS, 100 µL/well) were added and incubated at 37 
C for 30 min and then washed three times with washing buffer. The substrate solution (100 
µL/well) was added and incubated at 37 C for 15 min before adding 2 M H2SO4 (50 µL/well). 
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Absorbance values were measured at 450 nm.  
8.2 The determination of affinity 
The affinity of antibodies was determinated by using competitive indirect ELISA (ciELISA) 
and expressed by inhibition ratio values as followed. The microplates were firstly coated with 1μg 
of each homogenous coating antigen (100 μL/well) which was diluted with CB buffer and then 
incubated at 4 °C overnight. The coating solution in the ELISA plates was then discarded. 
Blocking buffer was then added to the plates (150 μL/well) which were placed in an incubator for 
1 h at 37 °C. The corresponding haptens (50 μL) at 10 μg/L were added to the wells as well as 50 
μL of antibody at titer dilution. After an incubation of 30 min at 37 °C, the plates were washed by 
PBST for two times. Goat anti-mouse IgG (HRP labeled) (1:5000, 100 μL/well) was then added 
and incubated for 30 min at incubator. Then 100 μL TMB substrate was added into wells and 
incubated for 15 min at 37 °C after washing. Then 2 mol L
−1 
H2SO4 (50 μL/well) was used to stop 
the enzymatic reaction and the OD values of 450 nm was measured. 
The inhibition ratio was calculated by using the following equation: 
Inhibition ratio = (B0–B)/ B0            (Eq. 2) 
where B0 and B are the responses the OD values in the absent of haptens and in the 
concentration of haptens at 10 mg/L. 
  
S31 
 
Table S5. The detailed information of antibodies titers and inhibition ratios from three immunizations 
Haptens Hapten Structures MPI 
1
st
 immunization  2
nd
 immunization 3
rd
 immunization 
Titers 
a
 Inhibition ratios 
b
 Titers Inhibition ratios Titers Inhibition ratios 
Hapten1a 
 
15.22 1233 1.09 3000 0.99 3360 0.92 
Hapten1b 
 
11.08 12666 61.02 28880 65.98 38400 77.52 
Hapten2a 
 
13.66 130 9.43 333 18.23 700 44.19 
Hapten2b 
 
11.02 380 5.01 600 14.13 1100 31.09 
Hapten2c 
 
6.90 2488 45.42 5600 73.24 7111 90.01 
a
The titers of antibody were determinated by noncompetitive ELISA and the dilution of antibody when furnishing ODmax between 1.5 and 2.0. Data were 
average values of 10 mice and each mouse obtained in triplicate.  
b
The inhibition ratio was calculated by using the following equation: Inhibition ratio = (B0–B)/ B0, where B0 and B are the responses the OD values in the 
absent of haptens and in the concentration of haptens at 10 mg/L. Data were average values of 10 mice and each mouse obtained in triplicate. 
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